A5 Pill - white round, 6mm
Generic Name: ponatinib
Pill with imprint A5 is White, Round and has been identified as Iclusig 15 mg. It is supplied by ARIAD Pharmaceuticals, Inc.
Iclusig is used in the treatment of Acute Lymphoblastic Leukemia; Chronic Myelogenous Leukemia and belongs to the drug classes BCR-ABL tyrosine kinase inhibitors, multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Iclusig 15 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for A5
Iclusig
- Generic Name
- ponatinib
- Imprint
- A5
- Strength
- 15 mg
- Color
- White
- Size
- 6.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- BCR-ABL tyrosine kinase inhibitors, Multikinase inhibitors, VEGF/VEGFR inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- ARIAD Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 76189-0535 (Discontinued)
- Inactive Ingredients
-
lactose monohydrate,
microcrystalline cellulose,
sodium starch glycolate type B potato,
silicon dioxide,
magnesium stearate
Note: Inactive ingredients may vary.
Related images for "A5"
More about Iclusig (ponatinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
